Class II malocclusion Oral Health
Conditions
Interventions
The research is designed as a randomized controlled clinical trial to evaluate dentofacial and dentoalveolar changes following mild to moderate Class II malocclusion correction using different fixed C
T1: Baseline records for all groups at enrolment date.
T2: 12 months after T1 (before full bonded orthodontic treatment for all groups).
T3: 18 – 30 months after T2 (after debonding of orthodontic tre
Sponsors
University of Alberta
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Females aged 10-13 years old and males aged 10-14 years old, with first premolars and first permanent molars, fully erupted 2. Class II molar relationship or at least ½ cusp on both sides 3. Dental crowding = 6mm 4. Overbite = 1mm
Exclusion criteria
Exclusion criteria: 1. Patients with missing/unerupted permanent first premolars and molars 2. Gingival recession (below CEJ) 3. TMJ trauma syndromes 4. History of Class II corrective orthodontics
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Evaluating maxillofacial, dentoalveolar bone remodeling, and tooth position changes associated with FCC treatment using fused MRI-CBCT images and fused CBCT-CBCT 2. Evaluate TMJ disc remodeling and disc-condyle relationship changes associated with FCC treatment using Fused MRI-CBCT images. 3. Evaluate TMJ clinical function changes associated with FCC treatment using a scoring scale to detect the severity of any dysfunction. The dental assessments will be conducted at all time points, whereas the TMJ assessments will be conducted at T1, T2, T3 & T4. Timepoints: T1: Baseline records for all groups at the enrolment date T2: 12 months after T1 (before full bonded orthodontic treatment for all groups) T3: 18 – 30 months after T2 (after debonding of orthodontic treatment for all groups) T4: 24 months after T3 | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Evaluating gingival attachment and periodontal condition changes associated with FCC treatment, using Clinical assessment at all 4 assessment times (T1, T2, T3, T4) 2. Evaluate the FCCs impact on participants' quality of life associated with FCC treatment using a self-reported Questionnaire: Patients will be provided with a questionnaire to evaluate their overall experience during the FCC treatment. Patients will be asked to answer this survey at all 4 assessment times (T1, T2, T3, T4). | — |
Countries
Canada
Outcome results
None listed